Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Biologic Products Receives Forbes Magazine Honor

publication date: Oct 21, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Biologic Products has been named to the 2009 list of "200 Best under a Billion" for Asia, a list put together by Forbes Magazine. China Biologic, which develops and markets plasma-based pharmaceutical products, has been growing through M&A transactions in China’s heavily regulated plasma sector. To create its list, Forbes selects listed companies with revenues of under $1 billion, solid growth history and excellent prospects. More details...

Stock Symbol: (OTCBB: CBPO)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners